A new brain imaging study led by researchers in the Department of Psychiatry and Behavioral Health in the Renaissance School of Medicine (RSOM) at Stony Brook University, and published in JAMA Network Open, uses a specialized type of magnetic resonance imaging (MRI) technique named neuromelanin-sensitive MRI to shed light on the link between chronic depression and the neurotransmitter dopamine. Dopamine plays important roles in many cognitive, emotional, and bodily functions and is a central cellular component to the reward/motivation system of the brain.
This article was originally published on MedicalXpress.com
